(S)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-2-methyl-3-(3-phenyl-1H-pyrrol-1-yl)propanamide

ID: ALA4869945

PubChem CID: 132227429

Max Phase: Preclinical

Molecular Formula: C22H18F3N3O2

Molecular Weight: 413.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@](O)(Cn1ccc(-c2ccccc2)c1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C22H18F3N3O2/c1-21(30,14-28-10-9-17(13-28)15-5-3-2-4-6-15)20(29)27-18-8-7-16(12-26)19(11-18)22(23,24)25/h2-11,13,30H,14H2,1H3,(H,27,29)/t21-/m0/s1

Standard InChI Key:  QTIQQQXWFXAXOL-NRFANRHFSA-N

Molfile:  

 
     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    4.2387  -10.2438    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.4215  -10.2438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8301  -10.9515    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.8400   -7.0699    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2528   -7.7798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6612   -7.0675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7184   -8.2008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7173   -9.0203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4253   -9.4293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1350   -9.0198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1322   -8.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4235   -7.7919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8383   -7.7859    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5476   -8.1918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5506   -9.0090    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0093   -9.4283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3012   -9.8364    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9630   -8.1865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7173  -10.6549    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.6692   -7.7754    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5494   -6.7895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7507   -6.9624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9606   -7.4958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4115   -8.1053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7734   -7.5798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1039   -8.3259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9160   -8.4102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3961   -7.7478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0583   -6.9991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2472   -6.9184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  1
  6  5  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  1  0
 14  5  1  0
 14 15  2  0
  8 16  1  0
 16 17  3  0
  5 18  1  0
  9  2  1  0
  2 19  1  0
 18 20  1  0
 20 24  1  0
 23 21  1  0
 21 22  2  0
 22 20  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4869945

    ---

Associated Targets(Human)

AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ar Androgen Receptor (5522 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 413.40Molecular Weight (Monoisotopic): 413.1351AlogP: 4.44#Rotatable Bonds: 5
Polar Surface Area: 78.05Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.09CX Basic pKa: CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -1.20

References

1. He Y, Hwang DJ, Ponnusamy S, Thiyagarajan T, Mohler ML, Narayanan R, Miller DD..  (2021)  Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer.,  64  (15.0): [PMID:34269581] [10.1021/acs.jmedchem.1c00439]

Source